The Conversation: FDA rejects new ALS drug; Chaminade partners with UN on sustainability

HPR President and General Manager José Fajardo offers an update on the FDA panel's ruling on a new drug to treat ALS, as well as his personal journey with the disease; A principal looks at the long term impacts of the pandemic and the water crisis on students; Chaminade University partners with the UN to tackle sustainability in the Pacific